A retrospective pharmacogenomic study identified the Stat1 SNP rs10208033’s association with Crizotinib-induced hepatotoxicity in Chinese patients with NSCLC treated with Crizotinib, highlighting the need for mechanistic exploration [56]. Here, STAT1 is linked to non-small cell lung carcinoma.